3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
49
Phase 1
26
Phase 3
13
Phase 1/2
13
Phase EARLY_PHASE1
5
Phase NA
1
Phase 4
1
Phase 2/3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Breast Neoplasms
27
Lymphoma
25
Precursor Cell Lymphoblastic Leukemia-Lymphoma
22
Lymphoma, Non-Hodgkin
21
Leukemia
21
Multiple Myeloma
18
Leukemia, Myeloid, Acute
18
Lymphoma, Large B-Cell, Diffuse
17
Hodgkin Disease
16
Myelodysplastic Syndromes
15
Lymphoma, Mantle-Cell
15
Lymphoma, Follicular
15
Leukemia, Lymphocytic, Chronic, B-Cell
14
Congenital Abnormalities
12
Lymphoma, B-Cell, Marginal Zone
11
Burkitt Lymphoma
11
Primary Myelofibrosis
10
Myeloproliferative Disorders
10
Lymphoma, Large-Cell, Immunoblastic
10
Lymphoma, T-Cell, Cutaneous
9
Leukemia, Myeloid, Chronic-Phase
9
Leukemia, Myeloid, Accelerated Phase
9
Neoplasms, Plasma Cell
8
Dendritic Cell Sarcoma, Interdigitating
8
Blast Crisis
8
Recurrence
7
Sezary Syndrome
6
Myelodysplastic-Myeloproliferative Diseases
6
Mycosis Fungoides
6
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
6
Interventions
Exercise
83
Standard of Care
45
Blood Specimen Collection
43
Methods
32
Therapeutics
28
Surveys and Questionnaires
27
Educational Status
25
Control Groups
20
Cognitive Behavioral Therapy
20
Interviews as Topic
18
Music Therapy
15
Biopsy
15
Acupuncture Therapy
15
Palliative Care
14
Resistance Training
13
Magnetic Resonance Spectroscopy
13
Early Intervention, Educational
13
Radiotherapy
10
Radiosurgery
10
Nutrition Assessment
9
Behavior Therapy
9
Yoga
8
Psychiatric Rehabilitation
8
Practice Guidelines as Topic
8
Patient Navigation
8
Counseling
8
Ultraviolet Therapy
7
Physical Therapy Modalities
7
Nutritional Status
7
Mindfulness
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Neoplasms
×
Cyclophosphamide
×
Clear all
NCT00578461
2016-04-22
REGKINE
Baylor College of Medicine
Phase NA
Terminated
26 enrolled
7 charts